Form D · Venture Capital Fund

Abingworth Bioventures 8 LP

London, X0 · CIK 0001811412

Offering snapshot reported May 18, 2020 · SEC filing

Reported sold: $132M
Investors reported: 13
Minimum accepted: $0
First sale: May 11, 2020

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
May 18, 2020	Initial	$132,200,000	No comparison	13	SEC filing

Offering details

Securities: Pooled investment fund
Exemptions: 06b, 3C, 3C.7
Duration over one year: Yes
Business combination: No

Sales commissions: $0 (estimated)
Finders' fees: $0 (estimated)
Form D file number: 021-367185

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
Asante Capital Group Advisors LLC	155178

Source: Form D, filed May 18, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

Each card uses that adviser's latest imported filing. Filing dates can differ; these disclosures do not confirm a current relationship.

Matched by reported Form D file number

ABINGWORTH BIOVENTURES 8 LP

Investment adviser: CARLYLE INVESTMENT MANAGEMENT L.L.C.

Gross asset value: $230M
Beneficial owners: 100
ADV minimum commitment: $0

Reported in Form ADV on Jul 7, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator APEX GROUP LONDON, United Kingdom Investor statements: Yes (provided to all investors) Related to adviser: No Other funds reporting this name →

Auditor ERNST & YOUNG LLP LONDON, United Kingdom Other funds reporting this name →

Custodian APEX GROUP LONDON, United Kingdom Related to adviser: No Other funds reporting this name →

Custodian BARCLAYS BANK PLC (LONDON) LONDON, United Kingdom Related to adviser: No Other funds reporting this name →

Provider details

Annual audit: Yes
Prime brokers: No
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: No

ERNST & YOUNG LLP
PCAOB 1438

Fund asset history · 4 annual observations

Scroll to see all columns →

Fiscal year	Gross assets	Beneficial owners	ADV filed
2022	$450,100,000	75	Mar 30, 2023
2023	$237,926,799	76	Mar 27, 2024
2024	$215,862,305	76	Mar 31, 2025
2025	$230,125,091	100	Mar 31, 2026

Filing source

Form ADV 2115592 · Jul 7, 2026 · Schedule D 7.B.(1), fund 805-9980486748

Reported by CARLYLE INVESTMENT MANAGEMENT L.L.C. (CRD 111128).

Other-Than Anual Amendment For Registered Adviser.

Official IAPD profile (latest public filing). Historical values on this page come from the SEC/IAPD filing archive; the public profile may show a newer filing.

Matched by reported Form D file number

ABINGWORTH BIOVENTURES 8 LP

Investment adviser: ABINGWORTH MANAGEMENT INC.

Gross asset value: $439M
Beneficial owners: 74
ADV minimum commitment: $50K

Reported in Form ADV on Oct 31, 2022. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator SANNE FIDUCIARY SERVICES (UK) LIMITED LONDON, United Kingdom Investor statements: Yes (provided to all investors) Related to adviser: No Other funds reporting this name →

Auditor DELOITTE LLP LONDON, United Kingdom Other funds reporting this name →

Custodian ROYAL BANK OF CANADA LONDON, United Kingdom Related to adviser: No Other funds reporting this name →

Custodian SANNE FIDUCIARY SERVICES (UK) LIMITED LONDON, United Kingdom Related to adviser: No Other funds reporting this name →

Provider details

Annual audit: Yes
Prime brokers: No
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: No

DELOITTE LLP
PCAOB 1147

ROYAL BANK OF CANADA
LEI ES7IP3U3RHIGC71XBU11

Fund asset history · 2 annual observations

Scroll to see all columns →

Fiscal year	Gross assets	Beneficial owners	ADV filed
2021	$466,406,000	73	Oct 1, 2021
2022	$439,117,000	74	Sep 2, 2022

Filing source

Form ADV 1674054 · Oct 31, 2022 · Schedule D 7.B.(1), fund 805-9980486748

Reported by ABINGWORTH MANAGEMENT INC. (CRD 157466).

Other-Than Anual Amendment For Registered Adviser.

Official IAPD profile (latest public filing). Historical values on this page come from the SEC/IAPD filing archive; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Abingworth Bioventures 8 Gp Lp	Promoter
Abingworth Llp	Promoter

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

38 Jermyn Street
London, X0, SW1Y 6DN
Phone: 44 0 20 7534 1508